Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000350512 | SCV000347279 | likely benign | Hyperinsulinism, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651327 | SCV001865821 | benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001651327 | SCV002408371 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549632 | SCV004790849 | benign | SLC16A1-related disorder | 2021-06-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |